Spots Global Cancer Trial Database for unresectable extrahepatic bile duct carcinoma

Every month we try and update this database with for unresectable extrahepatic bile duct carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma	NCT02856568	Non-Resectable ... Recurrent Chola... Stage III Extra... Stage III Intra... Stage IIIA Hila... Stage IIIB Hila... Stage IVA Extra... Stage IVA Hilar... Stage IVA Intra... Stage IVB Extra... Stage IVB Hilar... Stage IVB Intra... Unresectable Ex...	Cisplatin Gemcitabine Hyd... Laboratory Biom... Pharmacological... Ricolinostat	18 Years -	Mayo Clinic
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers	NCT03768414	Stage III Dista... Stage III Gallb... Stage III Intra... Stage IIIA Dist... Stage IIIA Gall... Stage IIIA Intr... Stage IIIB Dist... Stage IIIB Gall... Stage IIIB Intr... Stage IV Distal... Stage IV Gallbl... Stage IV Intrah... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex... Unresectable Ga... Unresectable In...	Cisplatin Gemcitabine Hyd... Nab-paclitaxel	18 Years -	SWOG Cancer Research Network
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT01093222	Extrahepatic Bi... Gallbladder Ade... Gallbladder Ade... Hilar Cholangio... Recurrent Extra... Recurrent Gallb... Undifferentiate... Unresectable Ex... Unresectable Ga...	Erlotinib Hydro... Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)
MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery	NCT01425879	Advanced Adult ... Localized Non-R... Recurrent Adult... Recurrent Gallb... Stage IV Distal... Stage IV Gallbl... Unresectable Ex... Unresectable Ga...	Akt Inhibitor M... Diagnostic Labo... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers	NCT03768414	Stage III Dista... Stage III Gallb... Stage III Intra... Stage IIIA Dist... Stage IIIA Gall... Stage IIIA Intr... Stage IIIB Dist... Stage IIIB Gall... Stage IIIB Intr... Stage IV Distal... Stage IV Gallbl... Stage IV Intrah... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex... Unresectable Ga... Unresectable In...	Cisplatin Gemcitabine Hyd... Nab-paclitaxel	18 Years -	SWOG Cancer Research Network
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery	NCT02042443	Adult Cholangio... Advanced Adult ... BCLC Stage C Ad... BCLC Stage D Ad... Hilar Cholangio... Localized Non-R... Recurrent Adult... Recurrent Child... Recurrent Extra... Recurrent Gallb... Stage II Gallbl... Stage III Child... Stage IIIA Gall... Stage IIIB Gall... Stage IV Childh... Stage IV Distal... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex...	Capecitabine Fluorouracil Laboratory Biom... Leucovorin Calc... Trametinib	-	National Cancer Institute (NCI)
Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery	NCT02042443	Adult Cholangio... Advanced Adult ... BCLC Stage C Ad... BCLC Stage D Ad... Hilar Cholangio... Localized Non-R... Recurrent Adult... Recurrent Child... Recurrent Extra... Recurrent Gallb... Stage II Gallbl... Stage III Child... Stage IIIA Gall... Stage IIIB Gall... Stage IV Childh... Stage IV Distal... Stage IVA Gallb... Stage IVB Gallb... Unresectable Ex...	Capecitabine Fluorouracil Laboratory Biom... Leucovorin Calc... Trametinib	-	National Cancer Institute (NCI)
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients With Advanced or Metastatic Biliary Cancers	NCT02392637	Stage III Intra... Stage IIIA Gall... Stage IIIB Gall... Stage IVA Gallb... Stage IVA Intra... Stage IVB Gallb... Stage IVB Intra... Unresectable Ex... Unresectable Ga...	Cisplatin Gemcitabine Hyd... Laboratory Biom... Nab-paclitaxel	18 Years -	M.D. Anderson Cancer Center
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma	NCT01093222	Extrahepatic Bi... Gallbladder Ade... Gallbladder Ade... Hilar Cholangio... Recurrent Extra... Recurrent Gallb... Undifferentiate... Unresectable Ex... Unresectable Ga...	Erlotinib Hydro... Sorafenib Tosyl...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: